- Journal of Clinical Pathology · 2
- Annals of Laboratory Medicine · 2
- US FDA · 2
- Clinical Chemistry · 2
- SEAP + SEOM · 1
- AMP + ASCO + CAP1
- UK NCC-BC/UK NEQAS/ECA · 1
- ASCO + CAP1
- Diagnostic Pathology · 1
- Archives of Pathology & Laboratory Medicine · 1
- European Journal of Human Genetics · 1
- Clinical and Translational Oncology · 1
腫瘤基因突變檢測1 份
- New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of SEAP and SEOM
次世代定序腫瘤基因套組1 份
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of AMP, ASCO and CAP
螢光原位雜交判讀2 份
- Updated UK Recommendations for HER2 assessment in breast cancer
- Guidelines for cytogenetic investigations in tumours
免疫組織化學生物標記判讀2 份
- HER2 Testing in Breast Cancer: ASCO/CAP Clinical Practice Guideline Focused Update
- PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics
微衛星不穩定性與錯誤配對修復檢測2 份
- Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer
- EMQN best practice guidelines for analysis and reporting of microsatellite instability in solid tumours
液態切片與循環腫瘤DNA2 份
- Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays
- Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
融合基因與染色體轉位偵測2 份
- Consensus Recommendations to Optimize the Detection and Reporting of NTRK Gene Fusions by RNA-Based Next-Generation Sequencing
- Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing
腫瘤突變負荷量分析2 份
- Expert consensus on the detection and clinical application of tumor mutational burden
- Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
標靶治療伴隨式診斷2 份
- Developing and Labeling In vitro Companion Diagnostic Devices for a Specific Group of Oncology Therapeutic Products
- In Vitro Companion Diagnostic Devices — Guidance for Industry and FDA Staff
血液腫瘤分子分型與微量殘存病灶2 份
- Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
- Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
分子檢測品質管制與驗證2 份
- Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies
- Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels
檢測報告臨床詮釋與分子腫瘤委員會2 份
- A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
- Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
定量聚合酶連鎖反應技術原理2 份
- The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
石蠟包埋檢體核酸萃取與品質評估2 份
- Pre-Analytical Considerations for Successful Next-Generation Sequencing (NGS): Challenges and Opportunities for Formalin-Fixed and Paraffin-Embedded Tumor Tissue (FFPE) Samples
- Why Formalin-fixed, Paraffin-embedded Biospecimens Must Be Used in Genomic Medicine: An Evidence-based Review and Conclusion
使用 Google 帳號登入,第一次登入時選擇科別即可開始;已經在用?直接登入
